Carla M. Nester, MD, MSA, FASN - 2025 Congress Highlights From Houston, Texas: Translating C3G and IC-MPGN Trials to Treatment in an Era of Complement Inhibition

Visit https://www.peervoice.com/JBN860 to view the entire programme with slides. After completing “Carla M. Nester, MD, MSA, FASN - 2025 Congress Highlights From Houston, Texas: Translating C3G and IC-MPGN Trials to Treatment in an Era of Complement Inhibition”, participants will be able to: Describe recent data updates from clinical trials and studies examining approved therapies in the management of C3G and IC-MPGN; Appraise the clinical significance of the data in the context of real-world evidence relating to outcomes across different patient populations with C3G and IC-MPGN; and Utilize available data to facilitate treatment decision-making in the management of C3G and IC-MPGN.

Listen